107 results
Page 4 of 6
DEFA14A
35ncfx5f7t s606
21 Jun 21
Additional proxy soliciting materials
9:25am
8-K
EX-99.1
scwb7op xynvfxpovo2
12 May 21
Diffusion Pharmaceuticals Reports First Quarter Financial Results
7:30am
8-K
EX-99.2
evbfz
12 May 21
Diffusion Pharmaceuticals Reports First Quarter Financial Results
7:30am
8-K
EX-99.1
6yx8auh3je
25 Mar 21
Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study
5:20pm
8-K
EX-99.1
elkjeq3 30wcd5
18 Mar 21
Regulation FD Disclosure
4:14pm
8-K
EX-99.1
vi9xzfn gpcu
17 Mar 21
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
4:36pm
8-K
EX-99.2
4xqtzs9d6qy tnnduz
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.1
345ef7 36sf1f
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.3
4zscfawxv
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.4
oamzly
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
424B5
koqh70
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
gbk6x3 ks
16 Feb 21
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
8:10am
8-K
EX-99.1
zaan0rmeg i72wl6ds
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
FWP
rrvo 7e0b
11 Feb 21
Free writing prospectus
9:56pm
FWP
aw9t2udg
11 Feb 21
Free writing prospectus
5:29pm
424B5
a20jvq6vqo84fdh
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
r7hmtq
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm